CA
NZ
UK
AU
IND
US
Adaptive Biotechnologies develops and commercializes immune-driven diagnostics and drug discovery technologies, with its clonoSEQ test serving as a leading minimal residual disease assay used in blood cancer monitoring. The company's platform leverages its proprietary immune sequencing technology to detect minimal residual disease with high …
Headquartered in Alachua, Florida, Axogen develops and commercializes products for the treatment of peripheral nerve injuries. The company's flagship product, Avance Nerve Graft, is a processed nerve allograft used for surgical repair of damaged peripheral nerves, complemented by the AxoGuard Nerve Protector and AxoGuard …
Cullinan Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapies for cancer. The company's pipeline centers on T cell engagers CLN-978 and CLN-049, alongside a licensed velinotamig program from Genrix and a continued collaboration with Taiho on zipalertinib, leveraging …
BridgeBio Pharma, Inc. (NASDAQ:BBIO), a Palo Alto, California-based commercial-stage biopharmaceutical company focused on genetic diseases, traded largely flat after announcing that the first participant has been dosed in ASCEND-ATTR, a new study evaluating long-term effects of its approved drug Attruby, known chemically as acoramidis, …
Moderna, Inc. (NASDAQ:MRNA), the Cambridge, Massachusetts-based biotechnology company known for its messenger RNA vaccine platform, saw its shares pull back sharply after a strong rally earlier in the week. Tuesday's roughly 14% gain was driven by positive Phase 3 data for the company's personalized …
Revolution Medicines (NASDAQ:RVMD) announced that the US Food and Drug Administration has approved RASONQUE (daraxonrasib), a once-daily oral tablet, for the treatment of adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent …
Boston Scientific Corporation (NYSE:BSX), a Marlborough, Massachusetts-based global medical technology company, saw its shares decline as investors weighed the combined impact of two negative disclosures within the same week. The company identified a cybersecurity incident on August 25 that has disrupted global operations, including …
Milestone Scientific Inc. (NYSE American:MLSS), a Roseland, New Jersey-based medical technology company that develops computerized drug delivery instruments for medical and dental applications, saw its shares rise after announcing a debt-to-equity conversion by three of its board directors. The company said the move eliminated …
Spyre Therapeutics, Inc. (NASDAQ:SYRE), a Waltham, Massachusetts-based clinical-stage biotechnology company focused on next-generation immunology therapies, saw its shares decline sharply after reporting topline results from the rheumatoid arthritis sub-study of its Phase 2 SKYWAY basket trial. The study evaluated SPY072, an anti-TL1A antibody, at …
Eli Lilly (NYSE:LLY) shares declined sharply in Wednesday's session, pulling back further after touching record highs last week. The drop followed reports that employers, including PepsiCo, are scaling back coverage for weight-loss drugs, alongside a benefits survey showing selective employer coverage of obesity treatments …
Please wait processing your request...